Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Day

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 1997
Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junctionC M Gomez, R Maselli, J E Gundeck, et al.
Neurology|December 30, 2004
Sudden cardiac death in myotonic dystrophy type 2B G H Schoser, K Ricker, C Schneider-Gold, et al.
Neurology|February 26, 2003
Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrumJ W Day, K Ricker, J F Jacobsen, et al.
Neurology|October 27, 2010
Clinical features of facioscapulohumeral muscular dystrophy 2J C de Greef, R J L F Lemmers, P Camaño, et al.
Neurology|July 15, 2011
Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophyD M Escolar, L P Hache, P R Clemens, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 1997
Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junctionC M Gomez, R Maselli, J E Gundeck, et al.
Neurology|December 30, 2004
Sudden cardiac death in myotonic dystrophy type 2B G H Schoser, K Ricker, C Schneider-Gold, et al.
Neurology|February 26, 2003
Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrumJ W Day, K Ricker, J F Jacobsen, et al.
Neurology|October 27, 2010
Clinical features of facioscapulohumeral muscular dystrophy 2J C de Greef, R J L F Lemmers, P Camaño, et al.
Neurology|July 15, 2011
Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophyD M Escolar, L P Hache, P R Clemens, et al.
Pageof 5